Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma.

Bedrose S, Miller KC, Altameemi L, Ali MS, Nassar S, Garg N, Daher M, Eaton KD, Yorio JT, Daniel DB, Campbell M, Bible KC, Ryder M, Chintakuntlawar AV, Habra MA

Open source

DOI: 10.1136/jitc-2020-001009
Published: 2020 Jul
Container: Journal for immunotherapy of cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/jitc-2020-001009,
  title = {Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma.},
  author = {Bedrose S and Miller KC and Altameemi L and Ali MS and Nassar S and Garg N and Daher M and Eaton KD and Yorio JT and Daniel DB and Campbell M and Bible KC and Ryder M and Chintakuntlawar AV and Habra MA},
  year = {2020},
  journal = {Journal for immunotherapy of cancer},
  doi = {10.1136/jitc-2020-001009},
  url = {https://doi.org/10.1136/jitc-2020-001009}
}

RIS

TY  - JOUR
TI  - Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma.
AU  - Bedrose S
AU  - Miller KC
AU  - Altameemi L
AU  - Ali MS
AU  - Nassar S
AU  - Garg N
AU  - Daher M
AU  - Eaton KD
AU  - Yorio JT
AU  - Daniel DB
AU  - Campbell M
AU  - Bible KC
AU  - Ryder M
AU  - Chintakuntlawar AV
AU  - Habra MA
PY  - 2020
JO  - Journal for immunotherapy of cancer
DO  - 10.1136/jitc-2020-001009
UR  - https://doi.org/10.1136/jitc-2020-001009
ER  -

APA

S, B., KC, M., L, A., MS, A., S, N., N, G., M, D., KD, E., JT, Y., DB, D., M, C., KC, B., M, R., AV, C., & MA, H. (2020). Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma.. Journal for immunotherapy of cancer. https://doi.org/10.1136/jitc-2020-001009

Source records

pubmed · retrieved 2026-09-26T10:33:25.990Z